Pregabalin versus SSRIs and SNRIs in benzodiazepine-refractory outpatients with generalized anxiety disorder: A post hoc cost-effectiveness analysis in usual medical practice in Spain
![Thumbnail](/xmlui/themes/Mirage2//images/thumbnails/thumn_cientif.png)
Identificadores![](/xmlui/themes/Mirage2//images/despl_identif.png)
Identificadores
URI: http://hdl.handle.net/20.500.11940/7253
PMID: 22745564
DOI: 10.2147/CEOR.S31102
ISSN: 1178-6981
Fecha de publicación
2012Título de revista
ClinicoEconomics and outcomes research : CEOR
Tipo de contenido
Artigo
![](/xmlui/themes/Mirage2//images/final_lines.png)